Rare diseases affect fewer than 200,000 people in the U.S., approximately 30 million individuals. Sadly, 3 out of 10 children with a rare disease won’t live to see their fifth birthday, yet the path ...
The U.S. Food and Drug Administration (FDA) issued a draft guidance titled Data Standards for Drug and Biological Product Submissions Containing Real-World Data on October 21, 2021. The guidance ...
The global pandemic has accelerated the Food and Drug Administration’s (FDA) encouragement of real-world data (RWD) and real-world evidence (RWE) (the clinical evidence derived from analysis of RWD), ...
Clinical research is in the midst of a data explosion, and that’s a good thing. Technological advances are enabling access to secure and de-identified data sources for researchers, and the ...
The European Medicines Agency (EMA) has finalized a document with recommendations on using the European Medicines Regulatory Network (EMRN) Data Quality Framework (DQF) when submitting premarket ...
Interviews conducted with biopharma executives in a Tufts CSDD study reveals growing RWD adoption and ROI across all phases of drug development SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- New ...
Industry leaders want to see more flexibility and clarity from the US Food and Drug Administration (FDA) as it seeks to finalize guidance on the use real-world data (RWD) from electronic health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results